Saturday, August 16, 2025

Latest

Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of directors with accomplished executives and thought leaders in the medical space with the appointment of Dr Bill Wilkerson, LL.D (Hon).

Dr Wilkerson is a highly accomplished executive in the areas of business, government, broadcasting, arts, and corporate crisis management. He has been an 8-time award-winner in workplace mental health, following an international initiative conducted from 1998 to 2012 to enforce the significance of mental health among major employers.

In terms of previous employment, Dr Wilkerson was previously President of Liberty Health, one of Canada’s largest benefits providers, and held executive roles at RBC, CBC, and the Toronto Symphony Orchestra. As an adviser for mental health, his career has been just as impressive, having worked with the NHL, the CFL, the Hockey Hall of Fame, Toronto Blue Jays, TSN, CTV, and more.

"I am pleased to join the board of directors of Champignon to help deploy, at long last, treatments of depression that work, work fast, restore health, fuel hope, animate workplace productivity, and save lives. The mission of this company is fundamental and enduring; to meet a pressing public need. This is what my twenty-two years of advocacy for mental health in the workplace has been all about. This directorship also permits me to support and help facilitate the vision of the extraordinarily skilled and dedicated physician-scientist Dr. Roger McIntyre, a world leader in a field that cries out for his kind of resolve, courage, compassion, and knowledge. I am humbled by, and grateful for, the opportunity to serve." 
Dr Bill Wilkerson

In conjunction with the appointment of Dr Bill Wilkerson, Joe Perino has resigned from Champignon’s board of directors.

Champignon Brands last traded at $1.63 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

SSR Mining Q2 Earnings: Cripple Creek Nearly Pays For Itself

Gold’s Next 12 Months Will Be the Trade of a Lifetime | Simon Marcotte – Northern Superior

Will The Government Will Quietly End The Dollar Using Gold | Andy Schectman

Recommended

First Majestic Posts Record Free Cash Flow In Second Quarter

Silver47 Identifies 35 Mineralized Prospects Across 55 Km Trend At Red Mountain

Related News

Champignon Brands To Resume Trading Today

Champignon Brands (CSE: SHRM) is expected to resume trading today after what was a nearly...

Friday, April 23, 2021, 08:22:55 AM

Champignon Closes AltMed Transaction, Partners With Leading Canadian Pharmacy

Champignon Brands (CSE: SHRM) today announced that it has partnered with a major pharmacy chain...

Thursday, April 30, 2020, 03:56:06 PM

Champignon Brands To Acquire Psilocybin Research Firm Tassili Life Sciences

Last night, Champignon Brands (CSE: SHRM) announced that they have signed a definitive agreement to...

Saturday, March 28, 2020, 01:12:34 PM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM

Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program...

Monday, June 8, 2020, 10:03:37 AM